Deccan Health Care Ltd carries a market capitalization of 339.06M, placing it among publicly traded companies globally. Its enterprise value stands at 180.74M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 339.06M |
| Enterprise Value | 180.74M |
Deccan Health Care Ltd currently has 24.75M shares outstanding.
| Shares Outstanding | 24.75M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Deccan Health Care Ltd trades at a trailing price-to-earnings ratio of 6.66. The price-to-sales ratio is 0.20, and the price-to-book ratio stands at 0.67.
| PE Ratio | 6.66 |
| PS Ratio | 0.20 |
| PB Ratio | 0.67 |
| P/TBV Ratio | 0.15 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Deccan Health Care Ltd trades at an EV/EBITDA multiple of 4.99 and an EV/FCF ratio of 64.78. The EV/Sales ratio of 0.22 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 4.99 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.22 |
| EV / EBITDA | 4.99 |
| EV / EBIT | 4.99 |
| EV / FCF | 64.78 |
Deccan Health Care Ltd maintains a current ratio of 3.81, meaning it holds 3.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.59, indicating elevated leverage, while an interest coverage ratio of 9.89 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 3.81 |
| Quick Ratio | 0.07 |
| Debt / Equity | 3.59 |
| Debt / EBITDA | 1.09 |
| Interest Coverage | 9.89 |
Deccan Health Care Ltd posts a return on equity of 8.59 and a return on invested capital of 2.45.
| Return on Equity (ROE) | 8.59 |
| Return on Assets (ROA) | 1.82 |
| Return on Invested Capital (ROIC) | 2.45 |
| Return on Capital Employed (ROCE) | 8.78 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.12 |
Over the trailing twelve months, Deccan Health Care Ltd has paid 7.78M in income taxes, reflecting an effective tax rate of 23.83.
| Income Tax | 7.78M |
| Effective Tax Rate | 23.83 |
Deccan Health Care Ltd's stock has declined approximately -32.17822% over the past 52 weeks. The 50-day moving average sits at 12.72, while the 200-day moving average is 14.03.
| Beta (5Y) | N/A |
| 52-Week Price Change | -32.17822% |
| 50-Day Moving Average | 12.72 |
| 200-Day Moving Average | 14.03 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Deccan Health Care Ltd generated 819.05M in revenue and converted that into 24.88M in net income, yielding earnings per share of 1.03. EBITDA reached 36.23M, while operating income came in at 36.23M.
| Revenue | 819.05M |
| Gross Profit | 315.23M |
| Operating Income | 36.23M |
| Pretax Income | 32.66M |
| Net Income | 24.88M |
| EBITDA | 36.23M |
| EBIT | 36.23M |
| Earnings Per Share (EPS) | 1.03 |
Deccan Health Care Ltd holds 24.51M in cash and equivalents against 39.62M in total debt, resulting in a net debt position of 23.18M. Total book value stands at 247.49M, with working capital of 956.83M providing operational flexibility.
| Cash & Cash Equivalents | 24.51M |
| Total Debt | 39.62M |
| Net Debt | 23.18M |
| Equity (Book Value) | 247.49M |
| Book Value Per Share | 10.24 |
| Working Capital | 956.83M |
Deccan Health Care Ltd operates with a gross margin of 38.49, reflecting its pricing power and cost economics. The operating margin of 4.42 and net profit margin of 3.04 provide insight into operational efficiency.
| Gross Margin | 38.49 |
| Operating Margin | 4.42 |
| Pretax Margin | 3.99 |
| Profit Margin | 3.04 |
| EBITDA Margin | 4.42 |
Deccan Health Care Ltd posts an Altman Z-Score of 1.66, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.66 |